Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis [Phase 1, Phase 2]
Astellas announced the completion of a combined Phase 1/2 safety, tolerability and efficacy study of ASK8007 for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants [Phase 1]
Phase 1 study to assess whether JNJ-39758979 affects plasma levels of methotrexate in adults with rheumatoid arthritis; the trial has comple…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating tocilizumab in combination with an oral contraceptive in patients with rheumatoid arthritis; results were posted in…
-
CLINICAL_TRIALS trial_result · 2013-03-12Clinical Trial Update: Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) [Phase 3]
PLANETRA, a Phase 3 trial evaluating CT-P13 in rheumatoid arthritis, has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis [Phase 2]
A Phase 2 study evaluating two dosing regimens of TRU-015 for rheumatoid arthritis was terminated, with results posted in 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 study evaluating lyophilized certolizumab pegol for safety and effectiveness in rheumatoid arthritis and prevention of joint damage;…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis [Phase 3]
Phase 3 clinical trial update evaluating safety and effectiveness of liquid Certolizumab Pegol for active rheumatoid arthritis and preventio…
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy [Phase 4]
A Phase 4 trial comparing Enbrel (etanercept) plus methotrexate versus Enbrel alone in adults with active rheumatoid arthritis despite metho…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]
A Phase 3 trial compared subcutaneous versus intravenous administration of tocilizumab (RoActemra/Actemra) in adults with moderate-to-severe…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 study comparing tocilizumab versus adalimumab in rheumatoid arthritis has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries
A completed clinical trial evaluating Humira (adalimumab) in active rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients [Phase 2, Phase 3]
This study evaluates subcutaneous abatacept in Japanese patients with rheumatoid arthritis, examining efficacy, pharmacokinetics, safety, an…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With Fostamatinib [Phase 1]
Phase 1 pharmacokinetic study evaluating rosuvastatin and simvastatin when given alone or in combination with fostamatinib in rheumatoid art…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study
Pfizer-sponsored observational trial evaluating the adoption of composite indices for assessing rheumatoid arthritis has completed, with res…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy
A validation study of RA-INF-Dx, a multigene molecular test intended to predict non-response to infliximab in rheumatoid arthritis, has been…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects [Phase 1]
Phase 1 study evaluating whether fostamatinib affects blood concentrations of warfarin in healthy subjects. Rheumatoid arthritis is listed a…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks [Phase 2]
Phase 2 trial results for CP-690,550 (tofacitinib) as monotherapy at three dose levels versus placebo in rheumatoid arthritis; results were …
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis [Phase 1, Phase 2]
Clinical trial update reporting a multiple-dose study of ATN-103 in subjects with active rheumatoid arthritis, conducted in Phase 1/2, which…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan [Phase 2]
Phase 2 study in Japan evaluating four doses of tofacitinib (CP-690,550) versus placebo, each with methotrexate, for rheumatoid arthritis; r…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis [Phase 1]
This report covers a Phase 1 study by Pfizer examining the effect of tasocitinib (CP-690,550) on cholesterol metabolism in patients with act…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids [Phase 4]
Phase 4 trial aimed at improving bone health in rheumatoid arthritis patients on chronic glucocorticoids; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Remicade Infusion Management Program
This update reports completion of Janssen's Remicade infusion management program trial evaluating infliximab for Crohn's disease and rheumat…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing two doses of CP-690,550 (tofacitinib) against placebo in rheumatoid arthritis; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications [Phase 3]
Phase 3 trial comparing two doses of Xeljanz (tofacitinib) versus placebo in rheumatoid arthritis patients on background arthritis medicatio…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial of CP-690,550 (tofacitinib) vs placebo in rheumatoid arthritis patients with inadequate response to TNF inhibitors on backgrou…